Authors
Rahi Abouk, Charles J. Courtemanche, Dhaval M. Dave, Bo Feng, Abigail S. Friedman, Johanna Catherine Maclean, Michael F. Pesko, Joseph J. Sabia, Samuel Safford
- Acknowledgements & Disclosure
- Author order is alphabetic and lead authorship is shared amongst all the authors. Research reported in this publication was supported by the National Institute on Drug Abuse of the National Institutes of Health under award number R01DA045016 (PI: Michael Pesko), R01DA039968 (PI: Dhaval Dave), and an Evidence for Action grant from the Robert Wood Johnson Foundation (grant #74869; PI: Friedman). Dr. Sabia acknowledges support from San Diego State University’s Center for Health Economics & Policy Studies (CHEPS), Dr. Courtemanche acknowledges support from the University of Kentucky’s Institute for the Study of Free Enterprise, and Dr. Abouk acknowledges support from William Paterson University’s Cannabis Research Institute. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.
- DOI
- https://doi.org/10.3386/w29216
- Published in
- United States of America